Giray ERGİN
(Yüksek İhtisas Üniversitesi, Koru Ankara Hastanesi, Üroloji Kliniği, Ankara, Türkiye)
Burak KÖPRÜ
(Yüksek İhtisas Üniversitesi, Koru Ankara Hastanesi, Üroloji Kliniği, Ankara, Türkiye)
Turgay EBİLOĞLU
(Gülhane Eğitim ve Araştırma Hastanesi, Üroloji Kliniği, Ankara, Türkiye)
Yusuf KİBAR
(Yüksek İhtisas Üniversitesi, Koru Ankara Hastanesi, Üroloji Kliniği, Ankara, Türkiye)
Murat DAYANÇ
(Özel Hekim, Ankara, Türkiye)
Yıl: 2019Cilt: 45Sayı: 1ISSN: 2149-3235 / 2149-3057Sayfa Aralığı: 78 - 83İngilizce

46 0
Our experience with ureterocystoplasty in bilateral functional kidneys
Objective: We have reviewed the data of the patients in order to evaluate the effectiveness of our ureterocystoplasty technique in augmentation cystoplasty operation. Material and methods: Data of a total of 16 patients with bilateral functional kidneys who had undergone augmentation ureterocystoplasty between January 1995 and June 2018 which were retrieved during the retrospective archive scanning were included in the study. Ultrasonography (USG), serum blood urea nitrogen and creatinine values and Technetium-99 DTPA (Tc-99 DTPA) scan were used to evaluate the renal function of the patients. Intravenous pyelography (IVP) and USG were used to evaluate the ureters before surgery. Magnetic resonance (MR) urographies were performed in our center. Results: Of the total 16 patients, 10 were male and 6 were female, while ages ranged from 1 to 24 years. Among 16 patients, the most common cause of neurogenic bladder etiology was meningomyelocele. In the urodynamic studies performed before the operation, it was determined that the bladder capacities of the patients were between 40-180 mL and the bladder compliances were 1.0-4.0 cc/cmH2 O. At postoperative 3rd months, it was determined that the bladder capacities of the patients were between 180-330 mL and the bladder compliances were between 6.0-24.0 cc/cmH2 O. Conclusion: Augmentation ureterocystoplasty seems to be an appropriate technique in which successful results are obtained with appropriate patient selection. Besides, complications that may occur due to use of ileal segment are avoided.
DergiAraştırma MakalesiErişime Açık
  • 1. Kurpad R, Kennelly MJ. The evaluation and management of refractory neurogenic overactive bladder. Curr Urol Rep 2014;15:444. [CrossRef]
  • 2. Eswara JR, Castellan M, González R, Mendieta N, Cendron M. The urological management of children with spinal cord injury. World J Urol 2018. DOI: doi: 10.1007/s00345-018-2433-1 [CrossRef]
  • 3. Johal NS, Hamid R, Aslam Z, Carr B, Cuckow PM, Duffy PG. Ureterocystoplasty: long-term functional results. J Urol 2008;179:2373-6. [CrossRef]
  • 4. Malone MJ, Izes JK, Hurley LJ. Carcinogenesis. The fate of intestinal segments used in urinary reconstruction. Urol Clin North Am 1997;24:723-8. [CrossRef]
  • 5. Babu R, Ragoori D. Bladder augmentation: Distal ureterocystoplasty with proximal ureteric reimplantation: A novel technique. J Indian Assoc Pediatr Surg 2012;17:165-7. [CrossRef]
  • 6. Stampfer DS, McDougal WS, McGovern FJ. The use of in bowel urology. Metabolic and nutritional complications. Urol Clin North Am 1997;24:715-22. [CrossRef]
  • 7. Malone MJ, Izes JK, Hurley LJ. Carcinogenesis. The fate of intestinal segments used in urinary reconstruction. Urol Clin North Am 1997;24:723-8. [CrossRef]
  • 8. Gosalbez R, Jr., Woodard JR, Broecker BH, Parrott TS, Massad C. The use of stomach in pediatric urinary reconstruction. J Urol 1993;150:438-40. [CrossRef]
  • 9. Eckstein HB MM. Uretero-cystoplastic. Act Urol 1973: 255-7.
  • 10. Bellinger MF. Ureterocystoplasty: a unique method for vesical augmentation in children. J Urol 1993;149:811-3. [CrossRef]
  • 11. Churchill BM, Aliabadi H, Landau EH, McLorie GA, Steckler RE, McKenna PH, et al. Ureteral bladder augmentation. J Urol 1993;150:716-20. [CrossRef]
  • 12. Landau EH, Jayanthi VR, Khoury AE, Churchill BM, Gilmour RF, Steckler RE, et al. Bladder augmentation: ureterocystoplasty versus ileocystoplasty. J Urol 1994;152:716-9. [CrossRef]
  • 13. Gericke D, Kovac W, Flamm H. Experimental studies on mycoplasma-induced leukemogenesis. Zentralbl Bakteriol Orig A 1971;218:343-55.
  • 14. Gosalbez R, Jr., Kim CO, Jr. Ureterocystoplasty with preservation of ipsilateral renal function. J Pediatr Surg 1996;31:970-5. [CrossRef]
  • 15. Ikeguchi EF, Stifelman MD, Hensle TW. Ureteral tissue expansion for bladder augmentation. J Urol 1998;159:1665-8. [CrossRef]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.